Viking Therapeutics (VKTX) Enterprise Value (2015 - 2026)
Viking Therapeutics (VKTX) reported Enterprise Value of $4.05 billion for Q2 2026, up 86.7% from $2.17 billion a year earlier and up 27.8% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Enterprise Value (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Enterprise Value came in at $2.03 billion; for FY2025, it came in at $3.33 billion, down 7.1% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of 82.7% (FY2020 to FY2025).
- By year, Enterprise Value came in at $3.59 billion in FY2024 (+139.0%), $1.5 billion in FY2023 (+158.7%), $580.13 million in FY2022 (+267.5%) and $157.84 million in FY2021 (-3.7%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value since Q3 2024.
- Year over year, Enterprise Value gained in four of the last eight quarters, with growth averaging 103.8%.
- The high point for year-over-year Enterprise Value in five years was Q3 2024 (growth of 737.7%); the low point was Q1 2022 (a decline of 80.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.17 billion (Q1 2026), $3.33 billion (Q4 2025) and $2.24 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn |
| 10 | Viking Therapeutics | 3.07 Bn | 542.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Bn |
| Mar 31, 2026 | 3.17 Bn |
| Dec 31, 2025 | 3.33 Bn |
| Sep 30, 2025 | 2.24 Bn |
| Jun 30, 2025 | 2.17 Bn |
| Mar 31, 2025 | 1.86 Bn |
| Dec 31, 2024 | 3.59 Bn |
| Sep 30, 2024 | 6.12 Bn |
| Jun 30, 2024 | 4.93 Bn |
| Mar 31, 2024 | 8.08 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 731.08 Mn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 580.13 Mn |
| Sep 30, 2022 | 53.57 Mn |
| Jun 30, 2022 | 52.71 Mn |
| Mar 31, 2022 | 47.22 Mn |
| Dec 31, 2021 | 157.84 Mn |
| Sep 30, 2021 | 275.18 Mn |
API Access
Viking Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();